Clinical Trials on Atrophic Maxilla in New Zealand

Total 615 results

Universal Skincare Institute
Lavish Beauty

Completed

Straberi Microneedling For Atrophic Acne (SAA)

Atrophic Acne Scar

United States
NYU College of Dentistry

Terminated

Bone Graft Particle Size on Bone Vitality and Volume

Bilateral Sinus Pneumatization | Posterior Maxillary Ridge Atrophy Due to Extraction

United States
Tavotek Biotherapeutics

Recruiting

A Study of TAVO101 in Atopic Dermatitis Patients

Atopic Dermatitis

New Zealand
Arrowhead Pharmaceuticals

Recruiting

Study of ARO-DUX4 in Adult Patients With Facioscapulohumeral Muscular Dystrophy Type 1

Facio-Scapulo-Humeral Dystrophy

New Zealand
Izun Pharma Ltd

Completed

Phase I-B Study to Evaluate the Safety, Tolerability and Efficacy of IZN-6NVS for the Treatment of AV and DIV

Atrophic Vaginitis

Israel, United States
Arrowhead Pharmaceuticals

Recruiting

Study of ARO-DM1 in Subjects With Type 1 Myotonic Dystrophy

Myotonic Dystrophy 1

New Zealand, Australia
Chinese University of Hong Kong

Recruiting

Prediction of Gastric Cancer in Intestinal Metaplasia and Atrophic Gastritis (GIMA)

Gastric Cancer | Intestinal Metaplasia | Atrophic Gastritis

Hong Kong
Actavis Inc.
Teva Pharmaceuticals USA

Completed

Study to Evaluate Equivalence of Estradiol Vaginal Cream 0.01% to Estrace® Cream 0.01% in Atrophic Vaginitis

Atrophic Vaginitis

United States
Ribon Therapeutics, Inc.

Recruiting

SAD/MAD Safety and PK Study of RBN-3143 in Healthy and Atopic Dermatitis Subjects

Atopic Dermatitis

Australia, New Zealand
Biogen

No longer available

Expanded Access Program (EAP) for Nusinersen in Participants With Infantile-onset (Consistent With Type 1) Spinal Muscular Atrophy (SMA)

Infantile-onset Spinal Muscular Atrophy

New Zealand, Colombia, Turkey
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Conjugated Estrogen Cream for Atrophic Vaginitis

Atrophy | Vaginitis | Atrophic Vaginitis

United States, Canada
ONL Therapeutics

Completed

ONL1204 Ophthalmic Solution in Patients With Geographic Atrophy Associated With Age-related Macular Degeneration

Geographic Atrophy

New Zealand, Australia
Mylan Pharmaceuticals Inc

Completed

A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic Vaginitis

Atrophic Vaginitis

United States
Novo Nordisk A/S

Completed

Pharmacokinetic Assessment of the Absorption of Estradiol in Postmenopausal Women With Atrophic Vaginitis

Menopause | Postmenopausal Vaginal Atrophy

Germany
University College Absalon
University of Southern Denmark; Danish Council for Independent Research; Sundhed...

Completed

Physical Function of Older Citizens During Municipality-based Rehabilitation

Fractures, Bone | Musculoskeletal Diseases | Musculoskeletal Pain | Muscle Weakness | Frailty | Sarcopenia | Aging | Rehabilitation | Musculoskeletal Injury | Weakness, Muscle

Denmark
Novo Nordisk A/S

Completed

Vagifem Low Dose for Postmenopausal Atrophic Vaginitis Symptoms

Menopause | Postmenopausal Vaginal Atrophy

United States, Canada
Columbia University
Muscular Dystrophy Association; Stevens Institute of Technology

Completed

Wearable Technology to Assess Gait Function in SMA and DMD

Duchenne Muscular Dystrophy | Spinal Muscular Atrophy Type 3

United States
Kessler Foundation
The Craig H. Neilsen Foundation

Unknown

Activity Dependent Rehabilitation Model to Improve Bone and Muscle Outcomes

Skeletal Muscle Hypertrophy | Nervous System | Atrophy, Disuse | Disuse Osteoporosis | Structural; Marker

United States
Akesobio Australia Pty Ltd

Completed

A Study of AK120 (IL-4Rα) in Healthy Subjects and Subjects With Moderate- to- Severe Atopic Dermatitis

Atopic Dermatitis

New Zealand, Australia
University of Southampton
National University Hospital, Singapore; Singapore Institute for Clinical Sciences and other collaborators

Enrolling by invitation

NiPPeR Randomised Trial - Child Follow Up Study (NiPPeR Child)

Neurobehavioral Manifestations | Allergy | Microbial Colonization | Growth Disorders | Atopic Dermatitis | Obesity, Childhood | Metabolic Disturbance | Cognition | Lifestyle | Breastfeeding | Nutrition, Healthy | Atopy

Singapore, United Kingdom, New Zealand
Memorial Sloan Kettering Cancer Center

Recruiting

A Study Collecting Health Information to Understand and Prevent Gastric Cancer

Gastric Cancer | Gastric Adenocarcinoma | Dysplasia | Gastric Intestinal Metaplasia | Gastric Atrophy

United States
Westat
National Institute of Neurological Disorders and Stroke (NINDS)

Terminated

Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Types II or III (NPTUNE01)

Spinal Muscular Atrophy Type II | Spinal Muscular Atrophy Type III

United States
InMode MD Ltd.

Recruiting

Evaluation of Safety and Efficacy of Morpheus8 Applicator for the Treatment of Focal Hyperhidrosis of the Axillae Using Radio Frequency

Hyperhidrosis Primary Focal Axilla

Israel, United States
Westat
National Institute of Neurological Disorders and Stroke (NINDS)

Terminated

Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Type I (NPTUNE 02)

Spinal Muscular Atrophy Type I

United States
Regeneron Pharmaceuticals
Sanofi

Completed

Safety and Tolerability of Dupilumab in Participants With Moderate to Severe Atopic Dermatitis

Atopic Dermatitis

Germany, New Zealand, Australia
Dyne Therapeutics

Recruiting

Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1 (ACHIEVE)

Myotonic Dystrophy Type 1 (DM1)

United Kingdom, France, Netherlands, Italy, Germany, New Zealand
Miramar Labs

Completed

Efficacy and Safety of the DTS-G2 System in Patients With Axillary Hyperhidrosis (DRI-UP)

Primary Focal Hyperhidrosis, Axilla

United States
Washington University School of Medicine

Active, not recruiting

Spinraza in Adult Spinal Muscular Atrophy (SAS)

Spinal Muscular Atrophy | Spinal Muscular Atrophy Type 3 | Spinal Muscular Atrophy Type II

United States, Canada
Novartis Gene Therapies

Active, not recruiting

Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi

SMA | Spinal Muscular Atrophy Type II | Spinal Muscular Atrophy Type I | Spinal Muscular Atrophy Type III

United States, Belgium, France, Japan, United Kingdom, Italy, Taiwan, Australia, Canada
Universität Duisburg-Essen
Weinmann Geräte für Medizin GmbH + Co. KG

Completed

Optimum Insufflation Capacity in NMD

Duchenne Muscular Dystrophy | Spinal Muscular Atrophy | Chronic Respiratory Insufficiency

Germany
TherapeuticsMD

Completed

TXV13-01 Estradiol Vaginal Softgel Capsules in Treating Postmenopausal Women With Symptoms of Vulvar and Vaginal Atrophy

Menopause | Vulvovaginal Atrophy | Dyspareunia | Painful Intercourse

United States
Scholar Rock, Inc.

Completed

An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy (TOPAZ)

Neuromuscular Diseases | Neuromuscular Manifestations | Atrophy | Muscular Atrophy | Spinal Muscular Atrophy | Muscular Atrophy, Spinal | Spinal Muscular Atrophy Type 3 | SMA | Spinal Muscular Atrophy Type 2

United States, Spain, Italy, Netherlands
AMO Pharma Limited

Recruiting

Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy (REACH CDM X)

Congenital Myotonic Dystrophy

United States, Canada, Australia, New Zealand
AMO Pharma Limited

Completed

Efficacy and Safety of Tideglusib in Congenital Myotonic Dystrophy

Congenital Myotonic Dystrophy

United States, Canada, New Zealand, Australia, United Kingdom
Amneal Pharmaceuticals, LLC

Completed

Study to Evaluate the Safety and Bioequivalence of Estradiol Vaginal Inserts, 10 mcg and Vagifem® 10 mcg and Compare to Placebo

Atrophic Vaginitis Due to Menopause

United States
Scholar Rock, Inc.

Active, not recruiting

Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab-ONYX (ONYX)

Neuromuscular Diseases | Neuromuscular Manifestations | Atrophy | Muscular Atrophy | Spinal Muscular Atrophy | Muscular Atrophy, Spinal | Spinal Muscular Atrophy Type 3 | SMA | Anti-myostatin | Spinal Muscular Atrophy Type II

United States, Spain, Belgium, Germany, Netherlands, Poland, Italy, France, United Kingdom
Albert Einstein College of Medicine
Novo Nordisk A/S; National Institute on Aging (NIA)

Completed

Accelerated Genital Tract Aging in HIV: Estradiol Clinical Trial

HIV Infection | Menopause | Aging | Dysbiosis | Vaginitis | Atrophic Vaginitis | Vaginal Atrophy | Menopause Related Conditions | Premature Aging

United States
Hospital for Special Surgery, New York

Terminated

Trial of Essential Amino Acid Supplementation in Protein Deficient Patients Following Total Knee Arthroplasty (Amino Acid)

Quad Atrophy

United States
Lumenis Be Ltd.

Unknown

Evaluation of the Safety and Efficacy of the NuEra Tight VRF for the Treatment of Vaginal and Vulvar Tissue Laxity

Vagina Atrophy

United States
Fox, Donald Munro, M.D., P.C.

Completed

Botulinum-assisted Orbital Fat Augmentation With PRP (Platelet-rich-plasma)

Orbital Atrophy

United States
Fox, Donald Munro, M.D., P.C.

Completed

Autologous Fat Augmentation of Orbital Volume Using a Closed Cannula Technique

Orbital Fat Atrophy

United States
Dr. Lila Nachtigall Rapid Medical Research, New...
Se-cure Pharmaceuticals Ltd.

Completed

A Twelve Week Study to Investigate the Efficacy of Femarelle®, for the Treatment of Post Menopausal Vaginal Atrophy

Vulvo Vaginal Atrophy

United States
Avidity Biosciences, Inc.

Recruiting

Phase 1/2 Study of AOC 1020 in Adults With Facioscapulohumeral Muscular Dystrophy (FSHD) (FORTITUDE)

Muscular Dystrophies | Muscular Dystrophy, Facioscapulohumeral | FSHD | Facio-Scapulo-Humeral Dystrophy | FMD | Facioscapulohumeral Muscular Dystrophy 1 | FSHD2 | FSHD1 | FMD2 | Fascioscapulohumeral Muscular Dystrophy | Fascioscapulohumeral Muscular Dystrophy Type 1 | Fascioscapulohumeral Muscular Dystrophy... and other conditions

United States, United Kingdom, Canada
Annexon, Inc.

Active, not recruiting

A Study Investigating the Efficacy and Safety of Intravitreal Injections of ANX007 in Patients With Geographic Atrophy (ARCHER)

Geographic Atrophy

United States, Australia, New Zealand
Apellis Pharmaceuticals, Inc.

Completed

Study of Pegcetacoplan (APL-2) Therapy in Patients With Geographic Atrophy (FILLY)

Geographic Atrophy

United States, Australia, New Zealand
Majmaah University
Scientific research unit, AIHMS New Delhi

Completed

Effect of Physical Therapy Modalities in Osteoarthritis

Osteo Arthritis Knee | Quadriceps Muscle Atrophy

India
Glenmark Pharmaceuticals Ltd. India

Completed

To Study Generic Estradiol 10 mcg Vaginal Tablets in the Treatment of Vulvar and Vaginal Atrophy in Post Menopausal Women.

Vulvar and Vaginal Atrophy

United States
Prasco LLC

Completed

Study to Evaluate the Equivalence of Estradiol Vaginal Cream to Reference Standard in the Treatment of Vaginal Atrophy

Vulvar and Vaginal Atrophy

United States
Ionis Pharmaceuticals, Inc.

Withdrawn

Safety and Efficacy of IONIS-FB-Lrx in up to 120 Patients 55 and Older With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

Geographic Atrophy | Age Related Macular Degeneration

Australia, United States, New Zealand
Allergan

Completed

Efficacy and Safety Study of Cyclosporine 0.010% to Treat Atopic Keratoconjunctivitis

Atopic Conjunctivitis

Canada, Czech Republic, United States, Italy, Israel, New Zealand, Spain, India, Germany, Australia, France, United Kingdom

Clinical Trials on Atrophic Maxilla in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations